<p>The APDGC was formed to conduct a genome-wide association study in individuals with neuropathologically confirmed Parkinson Disease (PD) and neuropathologically normal controls. The rationale for the study is that including only cases and controls with neuropathologically confirmed disease status will reduce diagnostic misclassification and increase power to detect novel genetic associations.</p>

Autopsy-Confirmed Parkinson Disease GWAS Consortium (APDGC)

Parkinson Disease study with SNP Genotypes (Array), SNP Genotypes (imputed) data on dbGaP (977 participants)